ventricular arrhythmias. In: Nava A, Rossi L, Thiene G, eds. Arrhythmogenic Right
Ventricular Cardiomyopathy-Dysplasia. Amsterdam, Netherlands: Elsevier;
1997:315-363.Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS et al. 2011 ACCF/AHA
Guideline for the Diagnosis and Treatment of Hypertrophic CardiomyopathyA Report
of the American College of Cardiology Foundation/American Heart Association Task
Force on Practice Guidelines. J Am Coll Cardiol. 2011;58(25):e212-e260.
doi:10.1016/j.jacc.2011.06.011.
Link M, Wang PJ, Haugh CJ, Homoud MK, Foote CB, Costeas XB, Estes NAM III.
Arrhythmogenic right ventricular dysplasia: clinical results with implantable
cardioverter defibrillator. J Interv Card Electrophysiol. 1997;1:41-8.
Marcus FI, McKenna WJ, Sherill D, Basso C, Bauce B, Bluemke DA et al. Diagnosis of
arrhythmogenic right ventricular cardiomyopathy/dysplasia proposed modification of
the task force criteria. Circulation. 2010;121:1533-41.
Richardson P, McKenna W, Bristow M, Marsch B, Mautner B, O”Connell J, Olsen E et
al. Report of the 1995 World Health Organization/International Society and
Federation of Cardiology Task Force on the definition and classification of
cardiomyopathies. Circulation. 1996;93:841.
Wichter T, Böcker D, Borggrefe M, Hammel D, Breithardt G, Block M. Cardioverter-
defibrillatory therapy. In: Nava A, Rossi L, Thiene G, editors. Arrhythmogenic right
ventricular cardiomyopathy-dysplasia. Amsterdam, Netherlands: Elsevier; 1997. p.
364-75.
Wichter T, Borggrefe M, Hoverkamp W, Chen X, Breithardt G. Efficacy of antiarrhythmic
drugs in patients with arrhythmogenic right ventricular disease: results in patients
with inducible and noninducible ventricular tachycardia. Circulation. 1992;86:29-37.
Wichter T, Hindricks G, Kottkamp H, Breithardt G, Borggrefe M. Catheter ablation of
ventricular tachycardia. In: Nava A, Rossi L, Thiene G, editors. Arrhythmogenic right
ventricular cardiomyopathy-dysplasia. Amsterdam, Netherlands: Elsevier; 1997. p.
376-91.